Jai Nagarkatti has been promoted to CEO of Sigma-Aldrich, effective Jan. 1, 2006, and will become a member of the board of directors. He is currently president and COO, and will retain the title of president. He succeeds Chairman and CEO David Harvey, who will remain on the board of directors. Nagarkatti has been employed by Sigma-Aldrich for 29 years.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Researchers find that a personalized medicine approach could help people who experience pain while taking statins, New Scientist reports.

US National Science Foundation is continuing its responsible research conduct training policy despite its flaws, ScienceInsider reports.

A CRISPR-themed meeting explored how the tool could and should be used, Wired reports.

In Science this week: database of proteins' effects on cancer, targeted error correction sequencing, and more.